TrialEBioMedicine2018

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.

Matthieu Duchmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.